KR910015300A - 부스피론 : 수면 무호흡증의 치료용도 - Google Patents

부스피론 : 수면 무호흡증의 치료용도 Download PDF

Info

Publication number
KR910015300A
KR910015300A KR1019910002288A KR910002288A KR910015300A KR 910015300 A KR910015300 A KR 910015300A KR 1019910002288 A KR1019910002288 A KR 1019910002288A KR 910002288 A KR910002288 A KR 910002288A KR 910015300 A KR910015300 A KR 910015300A
Authority
KR
South Korea
Prior art keywords
sleep apnea
buspyron
treatment
administering
administration
Prior art date
Application number
KR1019910002288A
Other languages
English (en)
Inventor
씨. 더멘트 윌리엄
알 . 로즈킨드 마아크
엘. 슈윔머 제프리
Original Assignee
원본미기재
브리스톨-마이어스 스퀴브 컴페니
스탠포드 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 브리스톨-마이어스 스퀴브 컴페니, 스탠포드 유니버시티 filed Critical 원본미기재
Publication of KR910015300A publication Critical patent/KR910015300A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

부스피론 : 수면 무호흡증의 치료용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 수면 무호흡증에 걸린 환자에게 치료적 유효량의 부스피론 또는 약리적으로 효과적인 그의 산부가염을 투여하는 것으로 이루어짐을 특징으로 하는 수면 무호흡증의 치료방법.
  2. 제1항에 있어서, 부스피론 히드로클로라이드를 사용하고 투여는 경구 경로에 의한 것이 특징인 치료방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910002288A 1990-02-12 1991-02-11 부스피론 : 수면 무호흡증의 치료용도 KR910015300A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47980390A 1990-02-12 1990-02-12
US479803 1995-06-07

Publications (1)

Publication Number Publication Date
KR910015300A true KR910015300A (ko) 1991-09-30

Family

ID=23905511

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910002288A KR910015300A (ko) 1990-02-12 1991-02-11 부스피론 : 수면 무호흡증의 치료용도

Country Status (12)

Country Link
EP (1) EP0442423B1 (ko)
JP (1) JP3168543B2 (ko)
KR (1) KR910015300A (ko)
AT (1) ATE116854T1 (ko)
CA (1) CA2036055A1 (ko)
DE (1) DE69106543T2 (ko)
DK (1) DK0442423T3 (ko)
ES (1) ES2069758T3 (ko)
GR (1) GR3015716T3 (ko)
HK (1) HK1005016A1 (ko)
HU (1) HUT56496A (ko)
IL (1) IL97054A (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
DK1066036T3 (da) 1998-02-27 2006-08-21 Univ Illinois Midler med serotoninrelateret aktivitet til behandling af sövnapnö
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
JP2008524332A (ja) 2004-12-20 2008-07-10 コレジウム ファーマシューティカル， インク． 睡眠傷害のための医薬組成物
CA2957667A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
EP2816024B8 (en) 2006-03-31 2018-04-04 Sunovion Pharmaceuticals Inc. Chiral amines
WO2010132521A1 (en) * 2009-05-13 2010-11-18 Sepracor Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof

Also Published As

Publication number Publication date
EP0442423B1 (en) 1995-01-11
DE69106543T2 (de) 1995-05-11
DK0442423T3 (da) 1995-03-20
IL97054A (en) 1995-10-31
ATE116854T1 (de) 1995-01-15
HU910436D0 (en) 1991-08-28
EP0442423A1 (en) 1991-08-21
DE69106543D1 (de) 1995-02-23
IL97054A0 (en) 1992-03-29
JP3168543B2 (ja) 2001-05-21
HK1005016A1 (en) 1998-12-18
HUT56496A (en) 1991-09-30
GR3015716T3 (en) 1995-07-31
ES2069758T3 (es) 1995-05-16
JPH0826997A (ja) 1996-01-30
CA2036055A1 (en) 1991-08-13

Similar Documents

Publication Publication Date Title
DK275488D0 (da) Indolonderivater
ATE37864T1 (de) Vinylphenolderivate, ihre herstellung und verwendung.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
KR930702000A (ko) 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
DE68911891D1 (de) Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung.
GR3017242T3 (en) Use of trifluoromethyl phenyl-tetrahydropyridines in the manufacture of a medicament for the treatment of anxio-depressive disorders.
KR970025615A (ko) 암 전이 억제제
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
PT920865E (pt) Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos
DE69428325T2 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
KR910015301A (ko) 수면 무호흡증의 치료방법
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
KR910009255A (ko) 과트리글리세라이드혈증과, 콜레스테롤혈증, 저레벨의 hdl질환 및 아테롬성 동맥경화증 치료제로서 사용되는 2-(페녹시 프로파놀아미노)에톡시 페녹시아세트산 유도체
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
KR940002268A (ko) 21-클로로-프레그난 유도체
KR890007737A (ko) 진토작용을 하는 약제

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid